Quick Answer
USANA HEALTH SCIENCES INC reported Total Revenue of $925.26 million for fiscal year 2025.
USANA HEALTH SCIENCES INC — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Revenue | $925.26M +8.3% |
$854.50M -7.2% |
$921.01M -7.8% |
$998.60M -15.8% |
$1.19B +4.6% |
$1.13B +7.0% |
| Revenue (ASC 606) | $925.26M +8.3% |
$854.50M -7.2% |
$921.01M -7.8% |
$998.60M -15.8% |
$1.19B +4.6% |
$1.13B +7.0% |
| Net Income | $10.76M -74.4% |
$42.03M -34.1% |
$63.79M -8.0% |
$69.35M -40.5% |
$116.50M -6.5% |
$124.66M +24.0% |
| Diluted EPS | $0.58 -73.5% |
$2.19 -33.6% |
$3.30 -8.1% |
$3.59 -37.3% |
$5.73 -2.2% |
$5.86 +32.9% |
| Total Assets | $742.91M -0.7% |
$748.19M +18.2% |
$632.76M +6.1% |
$596.55M +3.3% |
$577.74M -9.9% |
$640.89M +24.0% |
| Cash and Equivalents | $158.38M -12.9% |
$181.77M -45.0% |
$330.42M +14.6% |
$288.42M +20.3% |
$239.83M -23.1% |
$311.92M +32.8% |
| Stockholders Equity | $533.10M +0.2% |
$532.11M +7.0% |
$497.20M +14.4% |
$434.47M +10.0% |
$395.12M -10.5% |
$441.65M +25.6% |
| Operating Income | $37.43M -43.6% |
$66.32M -28.7% |
$93.07M -13.5% |
$107.61M -36.8% |
$170.19M -3.6% |
$176.49M +20.7% |
| Gross Profit | $724.40M +4.5% |
$693.29M -6.9% |
$744.32M -7.5% |
$804.71M -16.9% |
$968.57M +4.6% |
$925.53M +6.0% |
| Shares Outstanding | 18.28M -4.1% |
19.06M -0.3% |
19.13M -0.4% |
19.21M -1.0% |
19.39M -7.8% |
21.04M -2.8% |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | September 30, 2025 | $213.67M | +6.7% | -9.4% |
| Revenue (ASC 606) | September 30, 2025 | $213.67M | +6.7% | -9.4% |
| Net Income | September 30, 2025 | -$6.52M | -161.5% | -167.6% |
| Diluted EPS | September 30, 2025 | -$0.36 | -164.3% | -169.2% |
| Total Assets | September 30, 2025 | $726.59M | +8.2% | -1.1% |
| Cash and Equivalents | September 30, 2025 | $145.35M | -60.2% | -4.0% |
| Stockholders Equity | September 30, 2025 | $528.07M | -0.9% | -0.6% |
| Operating Income | September 30, 2025 | $1.22M | -92.2% | -92.7% |
| Gross Profit | September 30, 2025 | $164.85M | +2.4% | -11.2% |
| Shares Outstanding | September 30, 2025 | 18.27M | -4.1% | +0.1% |
- USANA HEALTH SCIENCES INC reported Total Revenue of $925.26 million for fiscal year 2025.
- USANA HEALTH SCIENCES INC showed an increase of +8.3% in Total Revenue compared to the prior fiscal year.
- USANA HEALTH SCIENCES INC reported Revenue (ASC 606) of $925.26 million for fiscal year 2025.
- USANA HEALTH SCIENCES INC showed an increase of +8.3% in Revenue (ASC 606) compared to the prior fiscal year.
- USANA HEALTH SCIENCES INC reported Net Income of $10.76 million for fiscal year 2025.
- USANA HEALTH SCIENCES INC showed a decrease of -74.4% in Net Income compared to the prior fiscal year.
- USANA HEALTH SCIENCES INC reported Diluted EPS of $0.58 per share for fiscal year 2025.
- USANA HEALTH SCIENCES INC showed a decrease of -73.5% in Diluted EPS compared to the prior fiscal year.
- USANA HEALTH SCIENCES INC reported Total Assets of $742.91 million for fiscal year 2025.
- USANA HEALTH SCIENCES INC showed a decrease of -0.7% in Total Assets compared to the prior fiscal year.
- USANA HEALTH SCIENCES INC reported Cash and Equivalents of $158.38 million for fiscal year 2025.
- USANA HEALTH SCIENCES INC showed a decrease of -12.9% in Cash and Equivalents compared to the prior fiscal year.
- USANA HEALTH SCIENCES INC reported Stockholders Equity of $533.10 million for fiscal year 2025.
- USANA HEALTH SCIENCES INC showed an increase of +0.2% in Stockholders Equity compared to the prior fiscal year.
- USANA HEALTH SCIENCES INC reported Operating Income of $37.43 million for fiscal year 2025.
- USANA HEALTH SCIENCES INC showed a decrease of -43.6% in Operating Income compared to the prior fiscal year.
- USANA HEALTH SCIENCES INC reported Gross Profit of $724.40 million for fiscal year 2025.
- USANA HEALTH SCIENCES INC showed an increase of +4.5% in Gross Profit compared to the prior fiscal year.
- USANA HEALTH SCIENCES INC reported Shares Outstanding of 18.28 million shares for fiscal year 2025.
- USANA HEALTH SCIENCES INC showed a decrease of -4.1% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: